MVEIX | VMVAX | MVEIX / VMVAX | |
Total Expense Ratio | 1.47 | 0.07 | 2,100% |
Annual Report Gross Expense Ratio | 1.47 | 0.07 | 2,100% |
Fund Existence | 28 years | 14 years | - |
Gain YTD | 13.702 | 8.454 | 162% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.1M | 32.5B | 0% |
Annual Yield % from dividends | 0.91 | 2.17 | 42% |
Returns for 1 year | 2.67 | 5.05 | 53% |
Returns for 3 years | 27.69 | 42.73 | 65% |
Returns for 5 years | 16.77 | 68.08 | 25% |
Returns for 10 years | -19.38 | 103.30 | -19% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HAP | 57.81 | 0.26 | +0.45% |
VanEck Natural Resources ETF | |||
STIP | 103.17 | 0.02 | +0.02% |
iShares 0-5 Year TIPS Bond ETF | |||
LIBD | 287.56 | N/A | N/A |
LifeX 2065 Inflation-Protected Longevity Income ETF | |||
ISHG | 75.98 | -0.24 | -0.31% |
iShares 1-3 Year International TrsBd ETF | |||
DIVP | 25.20 | -0.09 | -0.35% |
Cullen Enhanced Equity Income ETF |